ABIONYX Pharma
ABNX | PA
Overview
Corporate Details
- ISIN(s):
- FR0012616852 (+1 more)
- LEI:
- 969500785J7VIC5YPC96
- Country:
- France
- Address:
- 33 AVENUE GEORGES POMPIDOU, 31130 BALMA
- Website:
- https://abionyx.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ABIONYX Pharma is a new-generation biotechnology company focused on discovering and developing innovative therapies for diseases with no existing or effective treatments, including rare conditions. The company specializes in creating drugs for renal and ophthalmological diseases. It leverages its expertise in lipid science to develop novel treatments, including new High-Density Lipoprotein (HDL) vectors for targeted drug delivery and apolipoprotein A-I (apoA-I)-based therapeutics.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for ABIONYX Pharma.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-04 18:42 |
Declaration of Voting Results & Voting Rights Announcements
Total number of voting rights and capital / Information on the total number of …
|
English | 217.2 KB | |
| 2025-07-04 18:42 |
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 198.1 KB | |
| 2025-07-03 19:35 |
Transaction in Own Shares
Acquisition ou cession des actions de l'émetteur / Information relative au cont…
|
French | 532.3 KB | |
| 2025-07-03 19:35 |
Capital/Financing Update
Acquisition or disposal of the issuer's own shares / Information relating to th…
|
English | 557.0 KB | |
| 2025-06-27 19:14 |
Post-Annual General Meeting Information
Inside Information / Other news releases
|
English | 206.8 KB | |
| 2025-06-27 19:14 |
Post-Annual General Meeting Information
Informations privilégiées / Autres communiqués
|
French | 221.2 KB | |
| 2025-06-06 18:15 |
Pre-Annual General Meeting Information
Modalités de mise à disposition des documents préparatoires à l'AG
|
French | 273.9 KB | |
| 2025-06-03 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 198.3 KB | |
| 2025-06-03 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Total number of voting rights and capital / Information on the total number of …
|
English | 218.9 KB | |
| 2025-05-28 18:00 |
Earnings Release
Quarterly financial reporting / First quarter financial report
|
English | 315.4 KB | |
| 2025-05-28 18:00 |
Earnings Release
Information financière trimestrielle / Information financière du premier trimes…
|
French | 282.2 KB | |
| 2025-05-06 21:33 |
Declaration of Voting Results & Voting Rights Announcements
Total number of voting rights and capital / Information on the total number of …
|
English | 220.6 KB | |
| 2025-05-06 21:33 |
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 201.5 KB | |
| 2025-04-03 20:16 |
Declaration of Voting Results & Voting Rights Announcements
Total number of voting rights and capital / Information on the total number of …
|
English | 220.6 KB | |
| 2025-04-03 20:16 |
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 201.4 KB |
Automate Your Workflow. Get a real-time feed of all ABIONYX Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for ABIONYX Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-02-28 | N/A | Other | Buy | 53,913 | N/A |
